# Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD

> **NCT00506285** · PHASE3 · COMPLETED · sponsor: **University of Utah** · enrollment: 92 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate Transdermal System (MTS)
- **OTHER:** placebo patch

## Key facts

- **NCT ID:** NCT00506285
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2015-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00506285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00506285, "Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00506285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*